1000 Participants Needed

Sample Collection for Bladder Cancer Detection

CT
Overseen ByClinical Trials Referral Office
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on improving early detection of bladder cancer by collecting blood and urine samples from patients. Researchers aim to develop better tests for early detection of bladder cancer. Individuals who have noticed blood in their urine and have undergone scans or a bladder exam by a doctor might be suitable candidates.

As an unphased study, this trial provides a unique opportunity to contribute to groundbreaking research that could lead to earlier and more accurate detection of bladder cancer.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Why are researchers excited about this trial?

Researchers are excited about the "Bladder Bank" trial because it aims to enhance our understanding of bladder conditions by collecting and analyzing blood and urine samples, alongside reviewing patients' medical histories. Unlike traditional treatment methods that focus directly on alleviating symptoms, this observational approach could reveal new insights into the underlying causes and progression of bladder diseases. By gathering comprehensive data, this trial could pave the way for the development of more effective, targeted treatments in the future.

Who Is on the Research Team?

JB

John B. Kisiel, MD

Principal Investigator

Mayo Clinic in Rochester

Are You a Good Fit for This Trial?

Inclusion Criteria

The patient has been assessed for hematuria in an office setting using CT scans, ultrasounds or cystoscopy.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Sample Collection

Participants undergo blood and urine sample collection and have their medical records reviewed

Baseline (at enrollment)

Follow-up

Participants are monitored for safety and effectiveness after sample collection

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Non-Interventional Study

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+